Journal of Dual Diagnosis
Scope & Guideline
Advancing understanding of co-occurring disorders.
Introduction
Aims and Scopes
- Co-occurring Disorders Research:
The journal publishes studies on the prevalence, characteristics, and treatment of individuals suffering from both mental health disorders and substance use disorders, highlighting their interconnectedness. - Clinical Interventions and Treatment Strategies:
It focuses on evidence-based practices and innovative treatment approaches aimed at improving outcomes for patients with dual diagnoses, including pharmacological, psychological, and psychosocial interventions. - Impact of Trauma and Stress on Substance Use:
Research exploring the role of trauma, particularly post-traumatic stress disorder (PTSD), in the development and exacerbation of substance use disorders is a core area of focus. - Demographic and Sociocultural Influences:
The journal examines how various demographic factors, such as race, gender, and socioeconomic status, influence the manifestation and treatment of dual diagnosis, aiming to address health disparities. - Public Health Perspectives:
It contributes to the discourse on public health implications of dual diagnosis, including policy impacts and community health strategies, particularly in the context of emerging issues like the COVID-19 pandemic.
Trending and Emerging
- Impact of COVID-19 on Substance Use and Mental Health:
A significant number of recent studies have focused on how the COVID-19 pandemic has affected substance use patterns and mental health outcomes, showcasing the urgent need to adapt treatment and support mechanisms during public health crises. - Use of Technology in Treatment Delivery:
There is an increasing trend towards exploring digital interventions and telehealth solutions for managing dual diagnosis, indicating a shift towards modernizing treatment approaches to improve accessibility and engagement. - Understanding Trauma's Role in Dual Diagnosis:
Emerging research emphasizes the complexities of trauma in relation to substance use and mental health disorders, with a focus on tailored interventions addressing trauma-related symptoms. - Cultural and Racial Considerations in Treatment:
Recent publications have highlighted the importance of understanding cultural and racial factors in the treatment of dual diagnosis, striving for more inclusive and equitable healthcare practices. - Innovative Treatment Modalities:
The exploration of integrative treatment models, such as harm reduction and holistic approaches, is gaining traction, reflecting a broader acceptance of diverse strategies to address the multifaceted nature of dual diagnosis.
Declining or Waning
- Traditional Substance Use Treatment Models:
There appears to be a waning emphasis on conventional treatment models that do not integrate mental health services, as newer studies increasingly advocate for holistic, dual-focused approaches. - Single Disorder Studies:
Research focusing exclusively on either substance use disorders or mental health conditions, without considering their co-occurrence, is becoming less frequent, indicating a shift towards more integrated research frameworks. - Generalized Risk Factors without Contextual Analysis:
There is a decline in studies that discuss risk factors for substance use or mental health disorders in isolation, suggesting a preference for more nuanced analyses that consider the interplay of various factors in dual diagnosis. - Static Epidemiological Studies:
Epidemiological studies that do not address contemporary issues, such as the impact of recent societal changes or the pandemic on dual diagnosis, are less represented, indicating a need for more dynamic and contextually relevant research. - Focus on Non-Evidence-Based Interventions:
Research centered on interventions lacking rigorous evidence or those that do not demonstrate efficacy in dual diagnosis contexts is decreasing, as the journal prioritizes high-quality, evidence-based studies.
Similar Journals
Substance Abuse Treatment Prevention and Policy
Advancing knowledge to combat substance abuse.Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.
SUBSTANCE USE & MISUSE
Empowering professionals with evidence-based insights on substance misuse.SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.
BJPsych Advances
Transforming psychiatric science into clinical excellence.BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.
Addiction Science & Clinical Practice
Transforming addiction treatment through evidence-based insights.Addiction Science & Clinical Practice is a premier open-access journal dedicated to advancing the understanding and treatment of addiction through evidence-based research and clinical practice. Published by BMC in the United Kingdom since 2007, this journal has significantly impacted the fields of Clinical Psychology, Medicine, and Psychiatry and Mental Health, proudly securing a Q1 ranking in multiple categories as of 2023. With an emphasis on high-quality research, the journal provides an inclusive platform for the dissemination of innovative findings and clinical insights that address the complexities of addiction. Researchers, practitioners, and students alike benefit from its unrestricted access since 2012, allowing for widespread dissemination of knowledge. Located at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to lead the way in fostering collaboration and informing best practices in addiction science.
Canadian Journal of Addiction
Advancing the discourse on addiction.Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.
Annals of Clinical Psychiatry
Fostering Insightful Dialogue in Psychiatry.Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.
Advances in Dual Diagnosis
Pioneering Research for Integrated Mental Health SolutionsAdvances in Dual Diagnosis, published by EMERALD GROUP PUBLISHING LTD, serves as a vital resource for professionals and researchers in the fields of psychiatry and mental health. With an ISSN of 1757-0972 and E-ISSN 2042-8324, this journal has been at the forefront of dual diagnosis research since its inception in 2008, aiming to bridge the gap in knowledge and practice regarding the co-occurrence of mental health disorders and substance use issues. Rated in the Q4 category for Psychiatry and Mental Health, it ranks 31st out of 45 in Nursing and Psychiatric Mental Health and 408th out of 567 in Medicine and Psychiatry, providing a unique platform for showcasing emerging research, innovative treatment strategies, and case studies that enhance understanding of complex patient needs. While the journal is not openly accessible, its contributions are crucial for driving forward the academic discourse and practical applications surrounding dual diagnosis. As we look to the future through 2024 and beyond, the Advances in Dual Diagnosis journal continues to strive for excellence in disseminating knowledge that benefits practitioners and scholars alike.
Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry
Bridging Gaps in Psychiatry Through Open AccessKlinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.
AMERICAN JOURNAL ON ADDICTIONS
Connecting Experts to Combat AddictionThe AMERICAN JOURNAL ON ADDICTIONS, published by WILEY, stands as a premier publication within the realms of Clinical Psychology, Medicine, and Psychiatry. With its ISSN 1055-0496 and E-ISSN 1521-0391, the journal has been a critical resource since its inception in 1992, consistently evolving to encompass a wide scope of addiction research and its implications on public health. Renowned for its rigorous peer-reviewed articles, it boasts impressive rankings, including Q1 status in both Clinical Psychology and Medicine (miscellaneous) for 2023, and a respectable Q2 in Psychiatry and Mental Health. As a foundational platform for disseminating cutting-edge research, the journal aims to facilitate the exchange of knowledge among researchers, healthcare professionals, and educators alike. Its significant impact on the academic community is underscored by its Scopus rankings—placing it in the top 26% of Clinical Psychology journals and the top 28% in Medicine (miscellaneous). By fostering an understanding of addiction and its treatments, the AMERICAN JOURNAL ON ADDICTIONS plays an essential role in guiding innovative practices and shaping future policies within the field.
Current Addiction Reports
Exploring the frontiers of clinical psychology and psychiatry.Current Addiction Reports, published by SPRINGERNATURE, is a leading journal dedicated to the comprehensive study of addiction in its various dimensions, with a particular focus on the latest clinical developments and research in Clinical Psychology and Psychiatry and Mental Health. Since its inception in 2014 and through to 2024, the journal has established itself as a pivotal resource for researchers, professionals, and students alike, currently holding a prestigious Q1 ranking in both relevant categories. With an impressive Scopus rank of #46 in Clinical Psychology and #129 in Psychiatry and Mental Health, it occupies a significant position within the field, reflecting its commitment to high-quality scholarship and impactful findings. The journal offers open access options, ensuring that vital research is readily available to a global audience. By fostering a deeper understanding of addiction trends and innovative treatment methodologies, Current Addiction Reports plays an essential role in advancing knowledge and improving clinical practices.